1. Rajapakse S. Leptospirosis: clinical aspects. Clin Med. 2022;22(1):14.
2. Levett PN. Systematics of leptospiraceae. Curr Top Microbiol Immunol. 2015;387:11-20.
3. Levett PN. Leptospirosis. Clin Microbiol Rev. 2001;14(2):296-326.
4. David A. Haake and Paul N. Levett. Leptospira Species (Leptospirosis). In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases.
Ninth edition. Elsevier; 2020.
5. Samrot AV, Sean TC, Bhavya KS, et al. Leptospiral Infection, Pathogenesis and Its Diagnosis—A Review. Pathogens. 2021;10(2):145.
6. Vincent AT, Schiettekatte O, Goarant C, et al. Revisiting the taxonomy and evolution of pathogenicity of the genus Leptospira through the prism of genomics. Martins EAL, ed. PLoS Negl Trop
Dis. 2019;13(5):e0007270.
7. Thibeaux R, Girault D, Bierque E, et al. Biodiversity of Environmental Leptospira: Improving Identification and Revisiting the Diagnosis. Front Microbiol. 2018;9:816.
8. Torgerson PR, Hagan JE, Costa F, et al. Global Burden of Leptospirosis: Estimated in Terms of Disability Adjusted Life Years. PLoS Negl Trop Dis. 2015;9(10):e0004122.
9. Costa F, Hagan JE, Calcagno J, et al. Global morbidity and mortality of leptospirosis: a systematic review. PLoS Negl Trop Dis. 2015;9(9):e0003898.
10. Centers for Disease Control and Prevention. Leptospirosis. https://www.cdc.gov/leptospirosis/index.html (Accessed on February, 2024).
11. Hartskeerl RA, Collares-Pereira M, Ellis WA. Emergence, control and re-emerging leptospirosis: dynamics of infection in the changing world. Clin Microbiol Infect. 2011;17(4):494-501.
12. Munoz-Zanzi C, Groene E, Morawski BM, et al. A systematic literature review of leptospirosis outbreaks worldwide, 1970–2012. Rev Panam Salud Pública. 2020;44.
13. Khalil H, Santana R, de Oliveira D, et al. Poverty, sanitation, and Leptospira transmission pathways in residents from four Brazilian slums. PLoS Negl Trop Dis. 2021;15(3):e0009256.
14. Bradley EA, Lockaby G. Leptospirosis and the Environment: A Review and Future Directions. Pathog Basel Switz. 2023;12(9):1167.
15. Guerra MA. Leptospirosis. J Am Vet Med Assoc. 2009;234(4):472-478.
16. Turhan V, Hatipoğlu M. Leptospiroz: “Yeni fark edilen eski bir enfeksiyon hastalığı.” J Exp Clin Med. 2013;29(3s):163-168.
17. Saltoğlu, N. (2003). Leptospira infeksiyonları: Türkiye ve dünyada durum. Klimik Derg, 16(Suppl 2), 108-9.
18. Harran E, Hilan C, Djelouadji Z, Ayral F. Epidemiology of Leptospirosis: The First Literature Review of the Neglected Disease in the Middle East. Trop Med Infect Dis. 2022;7(10):260.
19. Ren SX, Fu G, Jiang XG, et al. Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature. 2003;422(6934):888-893.
20. Yang CW, Wu MS, Pan MJ, Hsieh WJ, Vandewalle A, Huang CC. The Leptospira outer membrane protein LipL32 induces tubulointerstitial nephritis-mediated gene expression in mouse
proximal tubule cells. J Am Soc Nephrol JASN. 2002;13(8):2037-2045.
21. Palaniappan RUM, Ramanujam S, Chang YF. Leptospirosis: pathogenesis, immunity, and diagnosis. Curr Opin Infect Dis. 2007;20(3):284-292.
22. Stevenson B, Choy HA, Pinne M, et al. Leptospira interrogans endostatin-like outer membrane proteins bind host fibronectin, laminin and regulators of complement. PloS One.
2007;2(11):e1188.
23. Fraga TR, Barbosa AS, Isaac L. Leptospirosis: aspects of innate immunity, immunopathogenesis and immune evasion from the complement system. Scand J Immunol. 2011;73(5):408-419.
24. Werts C, Tapping RI, Mathison JC, et al. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol. 2001;2(4):346-352.
25. Evangelista KV, Coburn J. Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses. Future Microbiol. 2010;5(9):1413-1425.
26. Haake DA, Levett PN. Leptospirosis in Humans. Curr Top Microbiol Immunol. 2015;387:65-97.
27. Bharti AR, Nally JE, Ricaldi JN, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis. 2003;3(12):757-771.
28. De Brito T, da Silva AMG, Abreu PAE. Pathology and pathogenesis of human leptospirosis: a commented review. Rev Inst Med Trop São Paulo. 2018;60:e23.
29. Gupta N, Wilson W, Ravindra P. Leptospirosis in India: a systematic review and meta-analysis of clinical profile, treatment and outcomes. Infez Med. 31(3):290-305.
30. P LT, L E. [Update on leptospirosis]. Rev Med Interne. 2019;40(5). doi:10.1016/j.revmed.2018.12.003
31. Karpagam KB, Ganesh B. Leptospirosis: a neglected tropical zoonotic infection of public health importance—an updated review. Eur J Clin Microbiol Infect Dis. 2020;39(5):835-846.
32. Toyokawa T, Ohnishi M, Koizumi N. Diagnosis of acute leptospirosis. Expert Rev Anti Infect Ther. 2011;9(1):111-121.
33. Puliyath G, Singh S. Leptospirosis in pregnancy. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2012;31(10):2491-2496.
34. Picardeau M, Bertherat E, Jancloes M, Skouloudis AN, Durski K, Hartskeerl RA. Rapid tests for diagnosis of leptospirosis: Current tools and emerging technologies. Diagn Microbiol Infect
Dis. 2014;78(1):1-8.
35. Wuthiekanun V, Chierakul W, Limmathurotsakul D, et al. Optimization of Culture of Leptospira from Humans with Leptospirosis. J Clin Microbiol. 2007;45(4):1363-1365.
36. Schreier S, Doungchawee G, Chadsuthi S, Triampo D, Triampo W. Leptospirosis: current situation and trends of specific laboratory tests. Expert Rev Clin Immunol. 2013;9(3):263-280.
37. Musso D, La Scola B. Laboratory diagnosis of leptospirosis: A challenge. J Microbiol Immunol Infect. 2013;46(4):245-252.
38. Koizumi N. Laboratory Diagnosis of Leptospirosis. Methods Mol Biol Clifton NJ. 2020;2134:277-287.
39. Gamage C, Sarathkumara Y, Weerakkodi V, Shiokawa K, Yoshimatsu K, Arikawa J. Development and evaluation of monoclonal antibody-based antigen capture enzyme-linked immunosor-
bent assay for the diagnosis of acute leptospirosis in humans. J Immunol Methods. 2018;463:134-136.
40. Soo ZMP, Khan NA, Siddiqui R. Leptospirosis: Increasing importance in developing countries. Acta Trop. 2020;201:105183.
41. Waggoner JJ, Pinsky BA. Molecular diagnostics for human leptospirosis. Curr Opin Infect Dis. 2016;29(5):440-445.
42. S T, M M, J B, et al. Risk factors and predictors of severe leptospirosis in New Caledonia. PLoS Negl Trop Dis. 2013;7(1).
43. Bandara K, Weerasekera MM, Gunasekara C, Ranasinghe N, Marasinghe C, Fernando N. Utility of modified Faine’s criteria in diagnosis of leptospirosis. BMC Infect Dis. 2016;16(1):446.
44. Kumar SS. In: Muruganathan A, editor. Indian Guidelines for the Diagnosis and Management of Human Leptospirosis. India: Medicine Update; 2013. p. 23–9.
45. Rodrigo C, Lakshitha de Silva N, Goonaratne R, et al. High dose corticosteroids in severe leptospirosis: a systematic review. Trans R Soc Trop Med Hyg. 2014;108(12):743-750.
46. Guerrier G, Lefèvre P, Chouvin C, D’Ortenzio E. Jarisch–Herxheimer Reaction Among Patients with Leptospirosis: Incidence and Risk Factors. Am J Trop Med Hyg. 2017;96(4):791-794.
47. Organization WH. Leptospirosis worldwide, 1999. Wkly Epidemiol Rec Relevé Épidémiologique Hebd. 1999;74(29):237-242.
48. Goarant C. Leptospirosis: risk factors and management challenges in developing countries. Res Rep Trop Med. 2016;7:49-62.
49. Mailloux M, Lambert R, Chenu M. Human vaccination against leptospirosis icterohaemorrhagiae. Med Hyg (Geneve). 1983; 41:1025–1030.
50. Teixeira AF, Fernandes LGV, Cavenague MF, et al. Adjuvanted leptospiral vaccines: Challenges and future development of new leptospirosis vaccines. Vaccine. 2019;37(30):3961-3973.